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Background: TB remains a leading cause of morbidity and mortality in 
developing countries, including Indonesia. Annual incidence of lung Tuberculosis 
in 2015 was 10.4 million worldwide. One of the challenging problems in TB 
control is the development of Multi Drug Resistant Tuberculosis (MDR-TB). 
There were an estimated 15,380 TB cases in Indonesia by 2015 with 1,860 
positive TB cases and 1,566 cases successfully treated. This study aimed to 
examine the predictor index for MDR-TB. 
Subjects and Method: This was a case-control study conducted at Dr. 
Moewardi Hospital, Surakarta, Central Java, from August to November 2017. The 
study subjects were selected by fixed disease sampling including 75 MDR-TB 
patients and 75 TB patients. The dependent variable was MDR-TB. The 
independent variables were medical history, co-morbidity (Diabetes Mellitus), 
drug side effect, drug-taking supervisor, and regularity of treatment. The data 
were collected by questionnaire and medical record. The data were analyzed by a 
multiple logistic regression. 
Results: MDR-TB Predictor Index increased with drug-taking supervisor (b = 
2.33; 95% CI= 3.83 to 27.91; p<0.001), drug-side effect (b= 0.73; 95% CI= 0.58 to 
7.45; p= 0.026), medical history (b= 2.35; 95% CI= 3.80 to 29.38; p<0.001). 
MDR-TB Predictor Index decreased by absence of type 2 Diabetes Mellitus (b = -
0.56; 95% CI= 0.18 to 1.78; p=0.033), regular treatment (b= -1.73; 95% CI= 0.06 
to 0.46; p<0.001). 
Conclusion: MDR-TB Predictor Index is determined by drug-taking supervisor, 
drug-side effect, medical history, Type 2 Diabetes Mellitus, and regular 
treatment. 
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